Singal R, Ferris R, Little J A, Wang S Z, Ginder G D
Department of Medicine, Division of Medical Oncology, University of Minnesota, Minneapolis, MN 55455-0362, USA.
Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13724-9. doi: 10.1073/pnas.94.25.13724.
Methylation of cytosines in the dinucleotide CpG has been shown to suppress transcription of a number of tissue-specific genes, yet the precise mechanism is not fully understood. The vertebrate globin genes were among the first examples in which an inverse correlation was shown between CpG methylation and transcription. We studied the methylation pattern of the 235-bp rho-globin gene promoter in genomic DNA from primary chicken erythroid cells using the sodium bisulfite conversion technique and found all CpGs in the promoter to be methylated in erythroid cells from adult chickens in which the rho-globin gene is silent but unmethylated in 5-day (primitive) embryonic red cells in which the gene is transcribed. To elucidate further the mechanism of methylation-induced silencing, an expression construct consisting of 235 bp of 5' promoter sequence of the rho-globin gene along with a strong 5' erythroid enhancer driving a chloramphenicol acetyltransferase reporter gene, rho-CAT, was transfected into primary avian erythroid cells derived from 5-day embryos. Methylation of just the 235-bp rho-globin gene promoter fragment at every CpG resulted in a 20- to 30-fold inhibition of transcription, and this effect was not overridden by the presence of potent erythroid-specific enhancers. The ability of the 235-bp rho-globin gene promoter to bind to a DNA Methyl Cytosine binding Protein Complex (MeCPC) was tested in electrophoretic mobility shift assays utilizing primary avian erythroid cell nuclear extract. The results were that fully methylated but not unmethylated 235-bp rho-globin gene promoter fragment could compete efficiently for MeCPC binding. These results are a direct demonstration that site-specific methylation of a globin gene promoter at the exact CpGs that are methylated in vivo can silence transcription in homologous primary erythroid cells. Further, these data implicate binding of MeCPC to the promoter in the mechanism of silencing.
二核苷酸CpG中胞嘧啶的甲基化已被证明可抑制许多组织特异性基因的转录,但其确切机制尚未完全阐明。脊椎动物珠蛋白基因是最早显示CpG甲基化与转录呈负相关的例子之一。我们使用亚硫酸氢钠转化技术研究了原代鸡红细胞基因组DNA中235bp的rho珠蛋白基因启动子的甲基化模式,发现该启动子中的所有CpG在成年鸡的红细胞中均被甲基化,此时rho珠蛋白基因沉默,但在该基因转录的5天(原始)胚胎红细胞中未甲基化。为了进一步阐明甲基化诱导沉默的机制,将一个由rho珠蛋白基因5'启动子序列的235bp以及驱动氯霉素乙酰转移酶报告基因rho-CAT的强5'红细胞增强子组成的表达构建体转染到来自5天胚胎的原代禽红细胞中。仅235bp的rho珠蛋白基因启动子片段在每个CpG处的甲基化导致转录受到20至30倍的抑制,并且这种效应不会被有效的红细胞特异性增强子的存在所克服。利用原代禽红细胞核提取物,通过电泳迁移率变动分析测试了235bp的rho珠蛋白基因启动子与DNA甲基胞嘧啶结合蛋白复合物(MeCPC)结合的能力。结果表明,完全甲基化而非未甲基化的235bp rho珠蛋白基因启动子片段能够有效地竞争MeCPC的结合。这些结果直接证明,珠蛋白基因启动子在体内甲基化的精确CpG处的位点特异性甲基化可使同源原代红细胞中的转录沉默。此外,这些数据表明MeCPC与启动子的结合在沉默机制中起作用。